| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |